Rare diseases
Investigational molecules
Locations
Back to Slovakia44 clinical trials in Svidnik, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia
SlovakiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaA study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia
SlovakiaStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
SlovakiaStudy on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
SlovakiaStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
SlovakiaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
SlovakiaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis
SlovakiaStudy on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atherosclerotic cardiovascular disease. Research includes evaluation of new therapeutic combinations and interventions for improving patient outcomes.
Multiple trials investigating novel compounds for reducing major adverse cardiovascular events.
Comprehensive research into chronic skin conditions, particularly hidradenitis suppurativa and chronic spontaneous urticaria. Studies evaluate both established and experimental treatments.
Clinical trials focusing on long-term management and innovative therapeutic approaches.
Studies addressing severe hypertriglyceridemia and related metabolic conditions. Research aims to evaluate new treatments for managing lipid disorders and associated cardiovascular risks.
Innovative approaches to treating complex metabolic disorders with novel therapeutic agents.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
